Aveanna Healthcare Holdings, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Aveanna Healthcare Holdings, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2019	FY2020	FY2022	FY2022	FY2023	FY2024	FY2026
Revenue	1,384	1,495	1,679	1,788	1,895	2,025	2,433
Cost of revenue	965	1,041	1,136	1,234	1,300	1,389	1,623
Gross profit	419	455	542	553	595	636	810
Selling, general and administrative	228	241	297	357	361	353	374
Operating income	39	-3.49	-36.1	-642	8.07	140	256
Interest expense	92.3	83	68.9	108	153	157	140
Interest income	0.21	0.35	0.25	0.68	0.33	0.5	2.83
Other non-operating income	-17	34.5	4.91	85.5	5.85	21.4	-6.4
Pre-tax income	-75	-51.7	-114	-664	-139	5.07	107
Income tax	1.49	5.32	3.47	-1.78	-4.47	16	-118
Net income	-76.5	-57.1	-117	-662	-135	-10.9	225
EBITDA	53.3	13.5	-15.6	-621	21.9	151	267
EPS, basic	-0.56	-0.40	-0.69	-3.57	-0.71	-0.06	1.11
EPS, diluted	-0.56	-0.40	-0.69	-3.57	-0.71	-0.06	1.05
Shares, basic (weighted)	137	141	0.17	186	190	193	204
Shares, diluted (weighted)	137	141	0.17	186	190	193	215

Balance sheet

	FY2019	FY2020	FY2022	FY2022	FY2023	FY2024	FY2026
Cash and equivalents		137	30.5	19.2	43.9	84.3	193
Receivables		173	219	221	237	265	313
Other current assets		11.3	9.2	9.81	9.45	13.2	29.9
Total current assets		341	279	270	315	393	560
Property, plant and equipment		32.7	31.4	22.8	20.5	17.4	16.7
Lease right-of-use assets		46.2	52	54.6	49.5	41.3	39
Goodwill	1,226	1,316	1,836	1,160	1,055	1,055	1,121
Intangible assets		73.6	103	95.9	94	89.6	92.6
Other non-current assets		7.63	7.83	86.2	58.2	45.5	16.9
Total assets		1,844	2,334	1,712	1,613	1,663	2,012
Deferred revenue				1.3
Short-term debt		9.91	8.6	9.2	9.2	9.2	13.3
Total current liabilities		260	345	326	355	402	424
Long-term debt		1,163	1,227	1,281	1,276	1,272	1,287
Lease liabilities		40.2	44.7	45.8	39.8	31.7	27.4
Other non-current liabilities		31	16.7	0.36	3.04	7.12	0.8
Total liabilities		1,577	1,696	1,716	1,740	1,785	1,817
Total debt		1,173	1,235	1,290	1,286	1,281	1,300
Paid-in capital		721	1,209	1,229	1,240	1,257	1,349
Retained earnings		-458	-575	-1,237	-1,371	-1,382	-1,157
Shareholders' equity	270	265	636	-6.31	-130	-124	194
Total equity	270	265	636	-6.31	-130	-124	194
Total liabilities and equity		1,844	2,334	1,712	1,613	1,663	2,012
Shares outstanding		142	185	189	191	193	211

Cash flow statement

	FY2019	FY2020	FY2022	FY2022	FY2023	FY2024	FY2026
Net income	-76.5	-57.1	-117	-662	-135	-10.9	225
Depreciation and amortization	14.3	17	20.6	21.3	13.8	10.8	10.5
Stock-based compensation	1.95	3.28	14.4	15.9	13.2	17.5	25.1
Deferred income tax	-0.92	-6.43	1.31	-0.12	1.02	1.04	-143
Change in receivables	3.34	8.56	-8.81	-3.23	-15.3	-28.6	-30.2
Change in payables	19.3	-6.81	-11.7	-3.93	-13.9	6.45	-6.23
Cash from operations	-8.71	117	-11.4	-48.4	22.7	32.6	126
Capital expenditures	-16.6	-15.2	-16
Acquisitions	-0.96	-178	-667	-2.01		0	-14.9
Cash from investing	-17.8	-194	-682	-25.3	-8.79	-6.32	-22.3
Stock issued		50	478			0	0.21
Cash from financing	21.9	211	586	62.4	10.8	14	5.41
Net change in cash	-4.67	134	-107	-11.3	24.7	40.3	109
Free cash flow	-25.4	101	-27.3
Interest paid	92.8	73.1	59	103	138	153	143
Income taxes paid	1.55	2.17	5.28	1.59	1.14	5.71	30.8

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $12.41 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	32.3%	Gross profit / revenue.
Operating margin	10.5%	Operating income / revenue.
EBITDA margin	11.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.9%	Pre-tax income / revenue.
Net margin	10.6%	Net income / revenue.
Operating cash flow margin	6.5%	Cash from operations / revenue.
Effective tax rate	-78.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	95.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	13.0%	Net income / average total assets.
Return on invested capital (ROIC)	14.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	14.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	0.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	20.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	10.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	10.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	27.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	13.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	12.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	83.5%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	77.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 5y	81.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	285.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	1.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value CAGR, 5y	-6.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	21.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	5.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	1.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	11.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	5.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	8.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.16x	Current assets / current liabilities.
Quick ratio	1.06x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.24x	(Cash + short-term investments) / current liabilities.
Debt / equity	4.52x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	61.6%	Total debt / total assets.
Liabilities / assets	86.3%	Total liabilities / total assets.
Net debt	$1.20B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	4.21x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.20x	Operating income / interest expense.
Working capital	$66.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	65.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.09B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.24x	Revenue / average total assets.
Fixed asset turnover	141x	Revenue / average property, plant and equipment.
Receivables turnover	7.72x	Revenue / average receivables.
Days sales outstanding	47 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.22	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$11.58	Revenue / diluted weighted shares.
Operating cash flow per share	$0.75	Cash from operations / diluted weighted shares.
Book value per share	$1.32	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$4.99	Tangible book value / shares outstanding.
Cash per share	$0.45	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$2.71B	Share price x shares outstanding.
Enterprise value	$3.91B	Market cap + total debt - cash - short-term investments.
P/E	9.86x	Market cap / net income. Only when net income is positive.
P/S	1.04x	Market cap / revenue.
P/B	9.43x	Market cap / shareholders' equity. Only when equity is positive.
P/OCF	16.1x	Market cap / cash from operations, when positive.
EV/Sales	1.50x	Enterprise value / revenue.
EV/EBIT	14.3x	Enterprise value / operating income, when both are positive.
EV/EBITDA	13.7x	Enterprise value / EBITDA, when both are positive.
Earnings yield	10.1%	Net income / market cap (the inverse of P/E).

What was Aveanna Healthcare Holdings, Inc.'s revenue in fiscal 2026?

Aveanna Healthcare Holdings, Inc. reported revenue of $2.43B for fiscal 2026, 20.2% higher than the year before.

Was Aveanna Healthcare Holdings, Inc. profitable in fiscal 2026?

Yes. Net income was $225.0M, a net margin of 9.2%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Aveanna Healthcare Holdings, Inc.